Clinical Trial Registration Policy
ETFLIN requires all clinical trials submitted to its journals to be prospectively registered in a WHO-recognized public registry, ensuring transparency and ethical compliance with international standards such as ICMJE and CONSORT.
Biomedical Standards
Clinical Trial Registration
In accordance with ICMJE, WHO, and COPE guidelines, all clinical trials must be prospectively registered in a publicly accessible registry.
What defines a Clinical Trial?
Any research study that prospectively assigns human participants to health-related interventions (drugs, surgical procedures, behavioral treatments, devices, etc.) to evaluate health outcomes.
Acceptable Registries
For a full list of approved registries, visit the WHO ICTRP.
Visit WHO ICTRP →Timing & Submission Requirements
Registration Timing
● Trials must be registered before the first participant is enrolled.
● Retrospective registration requires a strong justification and editorial review.
Submission Checklist
- Trial Registration Number
- Name of the Registry
- Publicly available entry
Reporting Guidelines
All manuscripts must follow the CONSORT (Consolidated Standards of Reporting Trials) guidelines. A completed checklist is mandatory.
Download CONSORT Statement →Non-compliance may result in immediate rejection. Exceptions are at the sole discretion of the editors.